Limin An

2PUBLICATIONS
8CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 25, 2025
mTORC1/2 inhibition induces tumor regression in CDK4/6 inhibitor-insensitive acral melanoma.

Jeremy A Bravo Narula, Kasturee Jagirdar, Sumaiya Begum

|Dec 30, 2021
Efficacy and Safety of Second-line Treatments in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: A Meta-analysis.

Limin An, Haotian Liao, Kefei Yuan

Pageof 1